These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5835439)

  • 1. Localization of plasminogen activator in neonatal lung in the presence of hyaline membrane disease.
    Roberts JT
    J Clin Pathol; 1965 Sep; 18(5):586-7. PubMed ID: 5835439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaline-membrane formation and pulmonary plasminogen-activator activity in various strains of mice.
    Lieberman J; Kellogg F
    Pediatrics; 1967 Jan; 39(1):75-81. PubMed ID: 5334048
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary venous vasculature in neonatal hyaline membrane disease.
    Lauweryns JM
    Science; 1968 Apr; 160(3824):190-2. PubMed ID: 5642570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolytic acivity in lung tissue from neonates with hyaline membrane disease.
    Ekelund H; Pandolfi M; Ostberg G; Bjernstad A
    Acta Paediatr Scand; 1973 Mar; 62(2):149-57. PubMed ID: 4570825
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental studies on proteolysis of hyaline membranes in vitro (author's transl)].
    Harms D; Buss G; Heimburger N; Pape GR
    Klin Wochenschr; 1975 Dec; 53(24):1147-53. PubMed ID: 1214451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fibrinolytic enzyme defect of hyaline membrane disease.
    LIEBERMAN J; KELLOGG F
    Calif Med; 1961 Nov; 95(5):278-82. PubMed ID: 14465183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen in the prevention of hyaline membrane disease.
    Ambrus CM; Weintraub DH; Choi TS; Eisenberg B; Staub HP; Courey NG; Foote RJ; Goplerud D; Moesch RV; Ray M; Bross ID; Jung OS; Mink IB; Ambrus JL
    Am J Dis Child; 1974 Feb; 127(2):189-94. PubMed ID: 4589496
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyaline membrane disease and a related spectrum of neonatal pneumopathies.
    Rosan RC
    Perspect Pediatr Pathol; 1975; 2():15-60. PubMed ID: 1129028
    [No Abstract]   [Full Text] [Related]  

  • 9. A deficiency of pulmonary fibrinolysis in hyaline-membrane disease.
    LIEBERMAN J; KELLOGG F
    N Engl J Med; 1960 May; 262():999-1004. PubMed ID: 14416840
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathways of fibrin turnover in lavage of premature baboons with hyperoxic lung injury.
    Idell S; Kumar A; Koenig KB; Coalson JJ
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):767-75. PubMed ID: 8118648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary plasminogen-activator activity in hyaline membrane disease. A reevaluation on human, bovine, and rabbit fibrin substrates.
    Lieberman J
    Pediatr Res; 1969 Jan; 3(1):11-8. PubMed ID: 5766408
    [No Abstract]   [Full Text] [Related]  

  • 12. Substrate specificity of plasminogen activator in the lungs of rabbits and rodents. Ionic enhancement of plasminogen activator activity.
    Lieberman J
    Lab Invest; 1968 Nov; 19(5):466-72. PubMed ID: 4235267
    [No Abstract]   [Full Text] [Related]  

  • 13. [Proceedings: Fibrinolysis studies on pulmonary hyaline membranes in vitro].
    Harms D; Buss G; Heimburger N; Pape GR
    Verh Dtsch Ges Pathol; 1974; 58():500. PubMed ID: 4142531
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Fibrinolytic activity in hyaline membrane disease.
    Lieberman J; Ekelund H
    Acta Paediatr Scand; 1973 Nov; 62(6):668-9. PubMed ID: 4800998
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of fibrinolysis in development of hyaline membrane disease in newborn rabbits.
    Sueishi K; Tanaka K; Oda T
    Virchows Arch A Pathol Anat Histol; 1978 Jun; 378(3):247-57. PubMed ID: 150112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaline membrane following total body radiation. Relation to lung plasminogen activator.
    FLEMING WH; SZAKACS JE; HARTNEY TC; KING ER
    Lancet; 1960 Nov; 2(7158):1010-1. PubMed ID: 13700230
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental fibrinolysis of tissues and studies on the problem of a relationship between fibrinolysis and the development of pulmonary hyaline membranes. Criticism of methods and development of a modification of the KSCN extraction method according to Astrup-Albrechtsen].
    Köhn D
    Arch Gynakol; 1967; 204(1):59-67. PubMed ID: 4230021
    [No Abstract]   [Full Text] [Related]  

  • 18. [New theory of fibrinolytic mechanism in the development of hyaline membrane disease in newborn infants].
    Uszyńska-Folejewska R; Uszyński M
    Pediatr Pol; 1975 Dec; 50(12):1513-5. PubMed ID: 127976
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of hyaline membrane disease with plasminogen. A cooperative study.
    Ambrus CM; Choi TS; Cunnanan E; Eisenberg B; Staub HP; Weintraub DH; Courey NG; Patterson RJ; Jockin H; Pickren JW; Bross ID; Jung OS; Ambrus JL
    JAMA; 1977 Apr; 237(17):1837-41. PubMed ID: 321823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary ultrastructure in neonatal hyaline membrane disease.
    Lauweryns JM; Bourgeois N
    Arch Dis Child; 1970 Feb; 45(239):146. PubMed ID: 5440188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.